Synergy Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 20-06-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 88.75 Cr
as on 20-06-2024
- Satisfied Charges ₹ 42.62 Cr
as on 20-06-2024
- Revenue -64.22%
(FY 2018)
- Profit -3065.60%
(FY 2018)
- Ebitda -419.65%
(FY 2018)
- Net Worth -46.68%
(FY 2018)
- Total Assets -12.30%
(FY 2018)
About Synergy Diagnostics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹88.75 Cr. The company has closed loans amounting to ₹42.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subodh Bawsay, Sanjay Bawsay, and Madhavi Bawsay serve as directors at the Company.
- CIN/LLPIN
U85195MH2000PTC129252
- Company No.
129252
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2000
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Synergy Diagnostics Private Limited offer?
Synergy Diagnostics Private Limited offers a wide range of products and services, including Injectable Products, Pharmaceutical Injectables, Rabies Vaccine, Calcium Tablet, Calcium Carbonate Tablet, Immunomodulator Drugs, Normal Immunoglobulin Injection, Vaccines, Anti-D immunoglobulin Injection, Hepatitis B Vaccine.
Who are the key members and board of directors at Synergy Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavi Bawsay  | Managing Director | 29-Jan-2001 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subodh Bawsay | Additional Director | 22-Sep-2021 | Current |
| Sanjay Bawsay | Director | 19-Oct-2000 | Current |
Financial Performance of Synergy Diagnostics.
Synergy Diagnostics Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 64.22% decrease. The company also saw a substantial fall in profitability, with a 3065.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synergy Diagnostics?
In 2018, Synergy Diagnostics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Fullerton India Credit Company Limited Creation Date: 03 Sep 2013 | ₹7.50 Cr | Open |
Bank Of India Creation Date: 18 Jan 2010 | ₹40.50 Cr | Open |
Bank Of India Creation Date: 17 Dec 2009 | ₹40.50 Cr | Open |
How Many Employees Work at Synergy Diagnostics?
Unlock and access historical data on people associated with Synergy Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synergy Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synergy Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
